NotesFAQContact Us
Search Tips
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ907844
Record Type: Journal
Publication Date: 2011-Jul
Pages: 10
Abstractor: As Provided
Reference Count: 42
ISSN: ISSN-1087-0547
A One Year Trial of Methylphenidate in the Treatment of ADHD
Wender, Paul H.; Reimherr, Frederick W.; Marchant, Barrie K.; Sanford, Mary Eve; Czajkowski, Laura A.; Tomb, David A.
Journal of Attention Disorders, v15 n1 p36-45 Jul 2011
Objective: To determine the effects of long-term methylphenidate treatment on symptom severity and social adjustment in adult ADHD. Method: Adults (n = 116) meeting operational diagnostic criteria for ADHD (the "Utah Criteria") entered a randomized double-blind crossover trial of methylphenidate and placebo. Participants who improved on immediate-release methylphenidate entered a 12-month, open-label trial. Outcomes were assessed using the Wender-Reimherr Adult Attention Deficit Disorder Scale (WRAADDS), Clinical Global Impression-Improvement (CGI-I), global assessment of functioning (GAF), and the Weissman Social Adjustment Scale (WSAS). Results: In the double-blind trial more patients improved (50% reduction of symptoms) receiving methylphenidate (74%) than placebo (21%, p = 0.001). During the open-label trial, symptom severity decreased 80% from baseline, and the WSAS decreased greater than 50% in all subscales. The average GAF improved significantly (p less than 0.0001). Conclusion: ADHD adults, who responded to methylphenidate in a short-term, placebo-controlled trial, responded to long-term treatment with marked improvements in ADHD symptoms and psychosocial functioning. (Contains 4 tables.)
SAGE Publications. 2455 Teller Road, Thousand Oaks, CA 91320. Tel: 800-818-7243; Tel: 805-499-9774; Fax: 800-583-2665; e-mail:; Web site:
Publication Type: Journal Articles; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A
Identifiers - Location: Utah